Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression
Addiction Biology · 2023
DOI: 10.1111/adb.13282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction Biology, 2023. Verfasst von Børge Holen und 18 weiteren Autor:innen. Beteiligte Einrichtung: NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Bipolar Disorder, Major Depressive Disorder, Schizophrenia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIMH NIH HHS, NIDA NIH HHS.
Themen: Sucht und Abhängigkeit, Depression
Abstract (Originalsprache)
Opioid use disorder (OUD) and mental disorders are often comorbid, with increased morbidity and mortality. The causes underlying this relationship are poorly understood. Although these conditions are highly heritable, their shared genetic vulnerabilities remain unaccounted for. We applied the conditional/conjunctional false discovery rate (cond/conjFDR) approach to analyse summary statistics from independent genome wide association studies of OUD, schizophrenia (SCZ), bipolar disorder (BD) and major depression (MD) of European ancestry. Next, we characterized the identified shared loci using biological annotation resources. OUD data were obtained from the Million Veteran Program, Yale‐Penn and Study of Addiction: Genetics and Environment (SAGE) (15 756 cases, 99 039 controls). SCZ (53 386 cases, 77 258 controls), BD (41 917 cases, 371 549 controls) and MD (170 756 cases, 329 443 controls) data were provided by the Psychiatric Genomics Consortium. We discovered genetic enrichment for OUD conditional on associations with SCZ, BD, MD and vice versa, indicating polygenic overlap with identification of 14 novel OUD loci at condFDR < 0.05 and 7 unique loci shared between OUD and SCZ ( n = 2), BD ( n = 2) and MD ( n = 7) at conjFDR < 0.05 with concordant effect directions, in line with estimated positive genetic correlations. Two loci were novel for OUD, one for BD and one for MD. Three OUD risk loci were shared with more than one psychiatric disorder, at DRD2 on chromosome 11 (BD and MD), at FURIN on chromosome 15 (SCZ, BD and MD) and at the major histocompatibility complex region (SCZ and MD). Our findings provide new insights into the shared genetic architecture between OUD and SCZ, BD and MD, indicating a complex genetic relationship, suggesting overlapping neurobiological pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NORMENT, Institute of Clinical Medicine, Division of Mental Health and Addiction, Oslo University Hospital, University of Oslo, Oslo, Norway.
- INSERM UMR-S1144, Paris University, Paris, France.
- Department of Cognitive Science, University of California San Diego, La Jolla, California, USA.
- Department of Radiology, University of California San Diego, La Jolla, California, USA.
- Multimodal Imaging Laboratory, University of California San Diego, La Jolla, California, USA.
- Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
ORCID-Profile: Børge Holen, Romain Icick, Markos Tesfaye
Förderung
- NIA NIH HHS
- NIMH NIH HHS
- NIDA NIH HHS
- Norges Forskningsråd
- Helse Sør-Øst RHF
- Horizon 2020 Framework Programme
- Stiftelsen Kristian Gerhard Jebsen
- Foundation for the National Institutes of Health
Zitieren
APA
Holen, B., Shadrin, A. A., Icick, R., Filiz, T. T., Hindley, G., Rødevand, L., O'Connell, K. S., Hagen, E., Frei, O., Bahrami, S., Cheng, W., Parker, N., Tesfaye, M., Jahołkowski, P., Karadag, N., Dale, A. M., Djurovic, S., Smeland, O. B., & Andreassen, O. A. (2023). Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression. Addiction Biology. https://doi.org/10.1111/adb.13282
Vancouver
Holen B, Shadrin AA, Icick R, Filiz TT, Hindley G, Rødevand L, et al. Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression. Addiction Biology. 2023. doi:10.1111/adb.13282
BibTeX
@article{Holen2023,
author = {Holen, Børge and Shadrin, Alexey A and Icick, Romain and Filiz, Tahir T and Hindley, Guy and Rødevand, Linn and O'Connell, Kevin S and Hagen, Espen and Frei, Oleksandr and Bahrami, Shahram and Cheng, Weiqiu and Parker, Nadine and Tesfaye, Markos and Jahołkowski, Piotr and Karadag, Naz and Dale, Anders M and Djurovic, Srdjan and Smeland, Olav B and Andreassen, Ole A},
title = {Genome‐wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression},
journal = {Addiction Biology},
year = {2023},
doi = {10.1111/adb.13282}
}
EUVIMED